Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.
She has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.
FDA Approves Tisagenlecleucel, the First CAR-T Cell Therapy in the United States
The FDA has approved the first chimeric antigen receptor-T (CAR-T) treatment, tisagenlecleucel (Kymriah), for the treatment of B-cell precursor acute lymphoblastic leukemia in certain pediatric and young adult patients. The therapy represents a new frontier in cancer care.
Comorbidities in Patients With Heart Failure: Treating the Whole Patient
Patients with heart failure tend to have other health issues, requiring cardiologists to understand how to care for heart failure while keeping in mind treatment for these other comorbidities, said panelists at the European Society of Cardiology Congress 2017, held August 26-30 in Barcelona, Spain.
An Eye on Cardiovascular Prevention: Begin in Childhood, Identify All Risk Factors
For each level of cardiovascular risk, lifestyle factors remain a significant contributor that can be modified to reduce risk. However, some risk will remain nonmodifiable and require therapy, according to panelists during a session on cardiovascular prevention at the European Society of Cardiology Congress 2017, held August 26-30 in Barcelona, Spain.
COMPASS: Rivaroxaban Plus Aspirin Protects Against Heart Attack, Stroke
Rivaroxaban plus aspirin has significant benefits for patients with peripheral artery disease (PAD) and stable coronary artery disease, according to the results of the COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS) trial, presented at the European Society of Cardiology Congress 2017, held August 26-30 in Barcelona, Spain.
CBO: Eliminating Cost-Sharing Reduction Payments Has Short-Term Pains, Long-Term Gains
Since taking office, President Donald Trump has toyed with the idea of eliminating the cost-sharing reduction (CSR) payments to insurers under the Affordable Care Act (ACA). Doing so would actually decrease the number of uninsured individuals starting in 2020, but would increase the federal deficit by $194 billion from 2017 through 2026, according to a new report released by the Congressional Budget Office (CBO).
Dr Patrick Conway Is Leaving CMS to Lead Blue Cross NC
Patrick Conway, MD, MSc, will leave his position as the deputy administrator for Innovation and Quality at CMS and the director of the Center for Medicare and Medicaid Innovation to lead Blue Cross and Blue Shield of North Carolina (Blue Cross NC).
AJMCtv® Interviews, August 2017
AJMC®TV interviews let you catch up with experts on what’s new and important about changes in healthcare. The interviews provide insights from key decision makers-from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. You can access the video clips at ajmc.com/interviews.
Bipartisan Group Reveals Proposals for Stabilizing the Healthcare Market
After Senator John McCain (R-Arizona) returned to Congress last week after surgery and a brain tumor diagnosis, he called on his fellow senators to put aside partisan differences and work together on healthcare reform. In the House of Representatives, a bipartisan group is trying to do just that.
Senate Republicans Vote on Motion to Proceed on ACA Repeal Debate
The Senate voted mostly along party lines in support of the motion to proceed to debate a replacement for the Affordable Care Act. Republican Senators Lisa Murkowski of Alaska and Susan Collins of Maine were the only 2 Republicans who voted against the motion.
Study Finds ACOs Have No Meaningful Impact on Medication Use or Adherence
Many accountable care organizations participating in the Medicare Shared Savings Program focus on disease control and medication use, but a new study published in JAMA Cardiology has found that the programs have not made any meaningful changes in medication use or adherence.
Tocilizumab More Cost-Effective at Treating Patients With RA Than Abatacept
In a study designed to identify the relevant cost per number needed to treat for the 2 biological disease-modifying antirheumatic drugs tocilizumab (TCZ) and abatacept, researchers determined that TCZ had a higher efficacy.
Without Votes for BCRA, McConnell Calls for Repeal and Delay of ACA
With plans to repeal and simultaneously replace the Affordable Care Act derailed now that 4 Republican senators have announced they would oppose the Better Care Reconciliation Act of 2017, Senate Majority Leader Mitch McConnell (R-Kentucky) is returning to an older plan: repeal and delay.
Four Republicans Now Oppose Senate Healthcare Bill
With 2 more Republicans announcing that they oppose the Senate healthcare bill, Senate Majority Leader Mitch McConnell (R-Kentucky) no longer has enough votes to pass the Better Care Reconciliation Act of 2017, which would repeal and replace parts of the Affordable Care Act.
Genome Sequencing Reveals Rare Disease Risk in 1 of 5 Generally Healthy Adults
An analysis of whole-genome sequencing (WGS) in healthy adults in the primary care setting found that 1 in 5 had a previously unrecognized variant associated with a rare disease, according to a study published in Annals of Internal Medicine.
Prescription Fills for High-Intensity Statins Increased from 2011 to 2014
From 2011 to 2014 the use of high-intensity statins following hospitalization for myocardial infarction (MI) increased progressively, according to a study published in Journal of the American College of Cardiology.
Rare Disease Can Be Misdiagnosed as Rheumatoid Arthritis
Whipple’s disease (WD) is a rare disease that predominantly affects middle-aged white men, and its diagnosis is often delayed because it is misdiagnosed as rheumatoid arthritis. A new study in Orphanet Journal of Rare Diseases aimed to describe clinical symptoms of WD and appropriate treatment.
5 Aspects of Medical Malpractice in the United States
On Thursday, the House of Representatives passed a bill that would reform medical malpractice by capping noneconomic damages at $250,000. Supporters say the reform would reduce frivolous claims and prevent doctors from practicing costly defensive medicine. Here’s a look at 5 aspects of medical malpractice in the United States.
Most Read Journal Articles (So Far) in 2017
With half a year behind us, The American Journal of Managed Care® (AJMC®) is reflecting back on the journal articles published through all journals in the franchise over the first half of 2017. The topics of interest ranged from alternative payment models to yoga and all focused on providing better care and better outcomes for patients.
Most Read News (So Far) of 2017
With the year 2017 halfway over, The American Journal of Managed Care® is looking back at the news of the first half of the year. Here we bring you the most read news stories, including conference coverage, a take on the new president’s first executive order, reimbursement challenges, and more.
Senate Reveals Healthcare Reform Bill
Republican leaders in the Senate unveiled a long-awaited healthcare reform bill, called the Better Care Reconciliation Act of 2017, that will roll back the Affordable Care Act’s taxes and Medicaid expansion, although at a slower timeline than included in the House of Representatives’ American Health Care Act, which was passed on May 4 by a vote of 217-213.
The Importance of Payer, Provider Collaboration in Payment Reform Efforts
Although the country is moving toward value-based payments, for providers it’s basically still a fee-for-service world, said Charles J. Fazio, MD, MS, of HealthPartners Health Plan, at America’s Health Insurance Plans’ Institute & Expo, held June 9-10 in Austin, Texas.
Embracing Value-Based Contracts for a Sustainable Healthcare System
With the sustainability and affordability of the US healthcare system in dire straits, now is the time for collaboration on new payment models, explained chief executive officers from a health plan and an insurer during a general session on the second day of America’s Health Insurance Plans’ Institute & Expo, held June 7-9 in Austin, Texas.